Figures & data
Figure 1. Summary of plan switching and treatment patterns among patients who faced formulary exclusion of apixaban by their Medicare Part D plan.
![Figure 1. Summary of plan switching and treatment patterns among patients who faced formulary exclusion of apixaban by their Medicare Part D plan.](/cms/asset/ad4da3c9-9f11-41a8-a785-50cbbae35c4b/icmo_a_2128189_f0001_b.jpg)
Table 1. Baseline characteristics of patients treated with apixaban at the end of 2016 who faced an upcoming formulary exclusion of apixaban by their Medicare Part D plan.